What pneumonia vaccine is recommended for patients aged 2-64?

The pneumonia vaccine recommended for patients aged 2-64 is Pneumovax (also known as PPSV23). This vaccine is specifically designed to protect against pneumococcal disease caused by 23 serotypes of Streptococcus pneumoniae. It is particularly indicated for individuals in certain risk categories, such as those with chronic medical conditions, immunocompromised states, or other conditions that make them susceptible to pneumonia.

While Prevnar 13 is also a pneumococcal vaccine, it is primarily recommended for infants, young children, and certain adults over 65 or those at high risk. The flu vaccine provides protection against influenza viruses but does not cover pneumococcal pneumonia. The BCG vaccine is primarily used for tuberculosis prevention and is not relevant for pneumococcal disease.

In summary, Pneumovax (PPSV23) is the appropriate vaccination for preventing pneumonia in individuals aged 2 to 64, particularly targeting those at increased risk due to underlying health issues.